NASDAQ:TRAX | EBITDA | First Tracks Biotherapeutics, Inc.

Complete source-backed ebitda history.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$52.69M
2025-03-31-$51.13M

Annual EBITDA

DateEBITDA

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.